Skip to content
healthcare.dev
Get a free key

Glyxambi

NDC 0597-0164, empagliflozin and linagliptin, tablet, film coated, from Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC
0597-0164
Status
Listed
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0164 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMPAGLIFLOZIN25 mg/1
  • LINAGLIPTIN5 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0597-0164-300059701643030 TABLET, FILM COATED in 1 BOTTLE (0597-0164-30)
0597-0164-390059701643930 BLISTER PACK in 1 CARTON (0597-0164-39) / 1 TABLET, FILM COATED in 1 BLISTER PACK
0597-0164-900059701649090 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ddbab689-f76c-488c-9613-4168d41dd730

  • NADAC price for package 00597016430

    GET /v1/drugs/nadac/00597016430

  • NADAC price for package 00597016439

    GET /v1/drugs/nadac/00597016439

  • NADAC price for package 00597016490

    GET /v1/drugs/nadac/00597016490

Use it

Look up 0597-0164 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0164 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0597-0164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.